WKN: | 885823 |
ISIN: | US3755581036 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Gilead Sciences-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 06. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2013 | 27,51 | 54,10 | 96,66% |
2 | 2000 | 1,45 | 2,72 | 87,59% |
3 | 2012 | 15,65 | 27,51 | 75,78% |
4 | 2005 | 6,47 | 11,22 | 73,42% |
5 | 1997 | 0,60 | 1,04 | 73,33% |
6 | 2001 | 2,72 | 4,56 | 67,65% |
7 | 1999 | 0,96 | 1,45 | 51,04% |
8 | 2014 | 54,10 | 80,14 | 48,13% |
9 | 2003 | 4,06 | 5,85 | 44,09% |
10 | 2021 | 46,28 | 64,94 | 40,32% |
11 | 2007 | 12,38 | 15,90 | 28,43% |
12 | 2024 | 73,10 | 89,83 | 22,89% |
13 | 2022 | 64,94 | 79,40 | 22,27% |
14 | 2015 | 80,14 | 94,04 | 17,34% |
15 | 2008 | 15,90 | 18,21 | 14,53% |
16 | 2011 | 13,79 | 15,65 | 13,49% |
17 | 2004 | 5,85 | 6,47 | 10,60% |
18 | 2006 | 11,22 | 12,38 | 10,34% |
19 | 2025 | 89,83 | 96,96 | 7,94% |
20 | 2019 | 55,13 | 58,85 | 6,75% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2016 | 94,04 | 68,53 | -27,13% |
2 | 2020 | 58,85 | 46,28 | -21,36% |
3 | 2009 | 18,21 | 15,04 | -17,41% |
4 | 2017 | 68,53 | 60,65 | -11,50% |
5 | 2002 | 4,56 | 4,06 | -10,96% |
6 | 2018 | 60,65 | 55,13 | -9,10% |
7 | 2010 | 15,04 | 13,79 | -8,31% |
8 | 2023 | 79,40 | 73,10 | -7,93% |
9 | 1998 | 1,04 | 0,96 | -7,69% |
10 | 2019 | 55,13 | 58,85 | 6,75% |
11 | 2025 | 89,83 | 96,96 | 7,94% |
12 | 2006 | 11,22 | 12,38 | 10,34% |
13 | 2004 | 5,85 | 6,47 | 10,60% |
14 | 2011 | 13,79 | 15,65 | 13,49% |
15 | 2008 | 15,90 | 18,21 | 14,53% |
16 | 2015 | 80,14 | 94,04 | 17,34% |
17 | 2022 | 64,94 | 79,40 | 22,27% |
18 | 2024 | 73,10 | 89,83 | 22,89% |
19 | 2007 | 12,38 | 15,90 | 28,43% |
20 | 2021 | 46,28 | 64,94 | 40,32% |